Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-CD19 CAR T-cells in Pediatric and Young Adult B-cell Malignancies
NCT02772198Phase 2Unknown
- Sponsor
- Sheba Medical Center
- Start
- Nov 2016
- Primary completion
- Jul 2022
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of UCD19 CAR-T in acute lymphoblastic leukemia (ALL), B-cell non-Hodgkin lymphoma, sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
UCD19 CAR-T
03
Conditions
acute lymphoblastic leukemia (ALL)B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT02772198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02772198.